GlassScriptPhysician profile
Marianne Digiovanni
NPI 1831169184
$854.59
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $103 · 2022: $294 · 2023: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $127.60 | 2019-2023 | Liletta |
| Therapeuticsmd, INC. | $88.11 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.96 | 2019-2023 | |
| Hologic Sales and Service, LLC | $63.35 | 2019-2023 | Aptima |
| Lupin INC. | $54.57 | 2019-2020 | |
| Urovant Sciences INC | $46.82 | 2022 | |
| Amag Pharmaceuticals, INC. | $44.68 | 2019-2020 | |
| Duchesnay USA Incorporated | $41.96 | 2019 | |
| Coopersurgical, INC. | $36.47 | 2023 | Endosee |
| Evofem Biosciences, INC. | $33.07 | 2022 | |
| Sumitomo Pharma America, INC. | $32.70 | 2023 | Myfembree |
| Organon LLC | $31.09 | 2022 | |
| Astellas Pharma US INC | $30.28 | 2022-2023 | Myrbetriq |
| Mayne Pharma Commercial LLC | $29.85 | 2022 | |
| Allergan, INC. | $26.39 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $25.71 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $16.69 | 2022 | |
| Agile Therapeutics, INC. | $16.25 | 2022 | |
| Daiichi Sankyo INC. | $15.40 | 2020 | |
| Shield Therapeutics INC | $13.67 | 2023 | Accrufer |
| Millicent US INC | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianne Digiovanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.